1-2 of 2
Martine J. van Vugt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The High-Affinity IgG Receptor, FcγRI, Plays a Central Role in Antibody Therapy of Experimental Melanoma

Lisette Bevaart, Marco J.H. Jansen, Martine J. van Vugt, J. Sjef Verbeek, Jan G.J. van de Winkel, Jeanette H.W. Leusen
Journal: Cancer Research
Cancer Res (2006) 66 (3): 1261–1264.
https://doi.org/10.1158/0008-5472.CAN-05-2856
Published: 01 February 2006
View article titled, The High-Affinity IgG Receptor, FcγRI, Plays a Central Role in Antibody Therapy of Experimental Melanoma
Open the PDF for The High-Affinity IgG Receptor, FcγRI, Plays a Central Role in Antibody Therapy of Experimental Melanoma in another window
Journal Articles

CpG-A and B Oligodeoxynucleotides Enhance the Efficacy of Antibody Therapy by Activating Different Effector Cell Populations

Heidi H. van Ojik, Lisette Bevaart, Christopher E. Dahle, Annie Bakker, Marco J. H. Jansen, Martine J. van Vugt, Jan G. J. van de Winkel, George J. Weiner
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5595–5600.
Published: 18 September 2003
View article titled, CpG-A and B Oligodeoxynucleotides Enhance the Efficacy of Antibody Therapy by Activating Different Effector Cell Populations
Open the PDF for CpG-A and B Oligodeoxynucleotides Enhance the Efficacy of Antibody Therapy by Activating Different Effector Cell Populations in another window